Article thumbnail

Crosstalk between Chemokine Receptor CXCR4 and Cannabinoid Receptor CB2 in Modulating Breast Cancer Growth and Invasion

By Mohd W. Nasser, Zahida Qamri, Yadwinder S. Deol, Diane Smith, Konstantin Shilo, Xianghong Zou and Ramesh K. Ganju
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2006). A
  2. (2006). A cannabinoid quinone inhibits angiogenesis by targeting vascular endothelial cells.
  3. (2009). Actin machinery and mechanosensitivity in invadopodia, podosomes and focal adhesions.
  4. (2008). Akt plays an important role in breast cancer cell chemotaxis to CXCL12.
  5. (2000). Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation.
  6. (2006). Cannabinoid receptor agonist-induced apoptosis of human prostate cancer cells LNCaP proceeds through sustained activation of ERK1/2 leading to G1 cell cycle arrest.
  7. (2006). Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes.
  8. (2006). Cannabinoid receptors as novel targets for the treatment of melanoma.
  9. (2011). Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.
  10. (2005). Cannabinoids downregulate PI3K/Akt and Erk signalling pathways and activate proapoptotic function of Bad protein.
  11. (2010). Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.
  12. (2005). Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow.
  13. (2009). Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications.
  14. (2010). Current and emerging biomarkers in breast cancer: prognosis and prediction.
  15. (2008). CXCR4 membrane expression in node-negative breast cancer.
  16. (2005). Defective p38 mitogen-activated protein kinase signaling impairs chemotaxic but not proliferative responses to stromal-derived factor-1alpha in acute lymphoblastic leukemia.
  17. (2008). Delta9-Tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivo.
  18. (2006). Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria.
  19. (2005). Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors.
  20. (2006). Expression of chemokine receptors predicts the site of metastatic relapse in patients with axillary node positive primary breast cancer.
  21. (2007). Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer.
  22. (2005). Focal adhesion kinase: in command and control of cell motility.
  23. (2010). High chemokine receptor CXCR4 level in triple negative breast cancer specimens predicts poor clinical outcome.
  24. (2004). How do chemokine/ chemokine receptor activations affect tumorigenesis? Novartis Found Symp 256: 74–89; discussion 89–91,
  25. (2004). Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4.
  26. (2001). Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor.
  27. (2003). Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors.
  28. (2001). Involvement of chemokine receptors in breast cancer metastasis.
  29. (2004). Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor
  30. (2002). Lck is required for stromal cell-derived factor 1 alpha (CXCL12)-induced lymphoid cell chemotaxis.
  31. (1993). Molecular characterization of a peripheral receptor for cannabinoids.
  32. (2003). NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4.
  33. (2006). Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma.
  34. (2008). Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
  35. (2009). Pten in stromal fibroblasts suppresses mammary epithelial tumours.
  36. (2004). Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells.
  37. (2005). Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation.
  38. (2009). Role of formation of an ERK-FAKpaxillin complex in migration of human corneal epithelial cells during wound closure in vitro.
  39. (2004). Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
  40. (2005). Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.
  41. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA.
  42. (2009). Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.
  43. (2003). T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer.
  44. (1998). The alphachemokine, stromal cell-derived factor-1alpha, binds to the transmembrane Gprotein-coupled CXCR-4 receptor and activates multiple signal transduction pathways.
  45. (1998). The many faces of G protein signaling.
  46. (2009). The roles of chemokine CXCL12 in embryonic and brain tumor angiogenesis.
  47. (2004). The significance of cancer cell expression of the chemokine receptor CXCR4.
  48. (2006). The stressregulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells.
  49. (2005). The therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritis.
  50. (2008). Translational research in breast cancer.
  51. (2003). Tumour-cell invasion and migration: diversity and escape mechanisms.
  52. (2002). Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4.